Гликемия под контролем: роль микро- и фитонутриентов

Сахарный диабет 2 типа (СД2) представляет собой глобальную эпидемию, обусловленную избыточным несбалансированным питанием и низкой физической активностью. Снижение массы тела на 5% и более улучшает чувствительность к инсулину, нормализует гликемию и снижает риск осложнений. Вместе с тем у пациентов с СД часто выявляется дефицит витаминов (С, группы В) и минералов (магния, цинка, хрома), что может усугублять метаболические нарушения и повышать риск развития осложнений. Коррекция дефицита микронутриентов, применение пищевых волокон (инулин) и растительных экстрактов (джимнема) способствуют улучшению углеводного и липидного обмена. Оптимальная стратегия диетотерапии включает сбалансированную диету, физическую активность и персонализированную нутритивную поддержку с включением витаминно-минерального комплекса и фитонутриентов.

1. Shu J, Jin W. Prioritizing non-communicable diseases in the post-pandemic era based on a comprehensive analysis of the GBD2019 from 1990 to 2019. Sci Rep. 2023 Aug 16; 13 (1): 13325. DOI: 10.1038/s41598‑023‑40595‑7

2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024 Nov 23; 404 (10467): 2077–2093. DOI: 10.1016/S0140-6736(24)02317‑1. Epub 2024 Nov 13. Erratum in: Lancet. 2025 Apr 5;405(10485):1146. DOI: 10.1016/S0140-6736(25)00620‑8

3. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016; 19 (2): 104–112. DOI: 10.14341/DM2004116-17.

4. Dyson PA, Twenefour D, Breen C, Duncan A, Elvin E, Goff L, Hill A, Kalsi P, Marsland N, McArdle P, Mellor D, Oliver L, Watson K. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med. 2018 May; 35 (5): 541–547. DOI: 10.1111/dme.13603. PMID: 29443421. The full document is available at: www.diabetes.org.uk/nutrition-guidelines.

5. Raynor HA, Champagne CM. Position of the Academy of Nutrition and Dietetics: Interventions for the Treatment of Overweight and Obesity in Adults. J Acad Nutr Diet. 2016 Jan; 116 (1): 129–147. DOI: 10.1016/j.jand.2015.10.031

6. Damms-Machado A, Weser G, Bischoff SC. Micronutrient deficiency in obese subjects undergoing low calorie diet. Nutr J. 2012 Jun 1; 11: 34. DOI: 10.1186/1475‑2891‑11‑34

7. Engel MG, Kern HJ, Brenna JT, Mitmesser SH. Micronutrient Gaps in Three Commercial Weight-Loss Diet Plans. Nutrients. 2018 Jan 20; 10 (1): 108. DOI: 10.3390/nu10010108

8. England E, Cheng C. Nutrition: Micronutrients. FP Essent. 2024 Apr; 539: 13–17. PMID: 38648170.

9. Blumberg JB, Cena H, Barr SI, Biesalski HK, Dagach RU, Delaney B, Frei B, Moreno González MI, Hwalla N, Lategan-Potgieter R, McNulty H, van der Pols JC, Winichagoon P, Li D. The Use of Multivitamin/Multimineral Supplements: A Modified Delphi Consensus Panel Report. Clin Ther. 2018 Apr;40(4):640–657. DOI: 10.1016/j.clinthera.2018.02.014.

10. Valdés-Ramos R, Guadarrama-López AL, Martínez-Carrillo BE, Benítez-Arciniega AD. Vitamins and type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets. 2015; 15 (1): 54–63. DOI: 10.2174/1871530314666141111103217

11. Pellegrini M, Rahimi F, Boschetti S, Devecchi A, De Francesco A, Mancino MV, Toppino M, Morino M, Fanni G, Ponzo V, Marzola E, Abbate Daga G, Broglio F, Ghigo E, Bo S. Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery. J Endocrinol Invest. 2021 Jul; 44 (7): 1413–1423. DOI: 10.1007/s40618‑020‑01439‑7

12. Balbi ME, Tonin FS, Mendes AM, Borba HH, Wiens A, Fernandez-Llimos F, Pontarolo R. Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2018 Mar 14; 10: 18. DOI: 10.1186/s13098‑018‑0318‑5

13. Kim Y, Oh YK, Lee J, Kim E. Could nutrient supplements provide additional glycemic control in diabetes management? A systematic review and meta-analysis of randomized controlled trials of as an add-on nutritional supplementation therapy. Arch Pharm Res. 2022 Mar; 45 (3): 185–204. DOI: 10.1007/s12272‑022‑01374‑6

14. Mohammad A, Falahi E, Barakatun-Nisak MY, Hanipah ZN, Redzwan SM, Yusof LM, Gheitasvand M, Rezaie F. Systematic review and meta-analyses of vitamin E (alpha-tocopherol) supplementation and blood lipid parameters in patients with diabetes mellitus. Diabetes Metab Syndr. 2021 Jul-Aug; 15 (4): 102158. DOI: 10.1016/j.dsx.2021.05.031

15. Mason SA, Parker L, van der Pligt P, Wadley GD. Vitamin C supplementation for diabetes management: A comprehensive narrative review. Free Radic Biol Med. 2023 Jan; 194: 255–283. DOI: 10.1016/j.freeradbiomed.2022.12.003

16. Bansal A, Hadimani CP. Low Plasma Ascorbate Levels in Type 2 Diabetic Patients With Adequate Dietary Vitamin C. J Lab Physicians. 2021 Jun; 13 (2): 139–143. DOI: 10.1055/s‑0041-1730751

17. Sinclair AJ, Taylor PB, Lunec J, Girling AJ, Barnett AH. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med. 1994 Nov; 11 (9): 893–8. DOI: 10.1111/j.1464-5491.1994.tb00375.x

18. Wilson R, Willis J, Gearry R, Skidmore P, Fleming E, Frampton C, Carr A. Inadequate Vitamin C Status in Prediabetes and Type 2 Diabetes Mellitus: Associations with Glycaemic Control, Obesity, and Smoking. Nutrients. 2017 Sep 9; 9 (9): 997. DOI: 10.3390/nu9090997

19. Mason SA, Keske MA, Wadley GD. Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2021 Feb; 44 (2): 618–630. DOI: 10.2337/dc20-1893

20. Nosratabadi S, Ashtary-Larky D, Hosseini F, Namkhah Z, Mohammadi S, Salamat S, Nadery M, Yarmand S, Zamani M, Wong A, Asbaghi O. The effects of vitamin C supplementation on glycemic control in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023 Aug; 17 (8): 102824. DOI: 10.1016/j.dsx.2023.102824

21. Montero D, Walther G, Stehouwer CD, Houben AJ, Beckman JA, Vinet A. Effect of antioxidant vitamin supplementation on endothelial function in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2014 Feb; 15 (2): 107–16. DOI: 10.1111/obr.12114

22. Serra M, Mollace R, Ritorto G, Ussia S, Altomare C, Tavernese A, Preianò M, Palma E, Muscoli C, Mollace V, Macrì R. A Systematic Review of Thiamine Supplementation in Improving Diabetes and Its Related Cardiovascular Dysfunction. Int J Mol Sci. 2025 Apr 22; 26 (9): 3932. DOI: 10.3390/ijms26093932

23. Chai Y, Chen C, Yin X, Wang X, Yu W, Pan H, Qin R, Yang X, Wang Q. Effects of water-soluble vitamins on glycemic control and insulin resistance in adult type 2 diabetes: an umbrella review of meta-analyses. Asia Pac J Clin Nutr. 2025 Feb; 34 (1): 118–130. DOI: 10.6133/apjcn.202502_34(1).0012

24. Thornalley PJ, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, Ahmed A, Rayman G, Bodmer CW. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 2007 Oct; 50 (10): 2164–70. DOI: 10.1007/s00125‑007‑0771‑4

25. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley PJ. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia. 2004 Dec; 47 (12): 2235–46. DOI: 10.1007/s00125‑004‑1582‑5

26. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev. 2005 Aug; 1 (3): 287–98. DOI: 10.2174/157339905774574383

27. Muley A, Fernandez R, Green H, Muley P. Effect of thiamine supplementation on glycaemic outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. BMJ Open. 2022; 12: e059834. DOI: 10.1136/bmjopen‑2021-059834

28. La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, Porta M. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions. Diabetologia. 1996 Nov; 39 (11): 1263–8. DOI: 10.1007/s001250050568

29. Ritorto G, Ussia S, Mollace R, Serra M, Tavernese A, Palma E, Muscoli C, Mollace V, Macrì R. The Pivotal Role of Thiamine Supplementation in Counteracting Cardiometabolic Dysfunctions Associated with Thiamine Deficiency. Int J Mol Sci. 2025 Mar 27; 26 (7): 3090. DOI: 10.3390/ijms26073090

30. Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E, Kellicut D, Sidawy AN. Thiamine (vitamin B1) improves endothelium-dependent vasodilatation in the presence of hyperglycemia. Ann Vasc Surg. 2006; 20: 653–658. DOI: 10.1007/s10016‑006‑9055‑6

31. Reimers JI, Andersen HU, Pociot F. Nikotinamid og forebyggelse af insulinkraevende diabetes mellitus. Rationale, virkningsmekanisme, toksikologi og kliniske erfaringer. ENDIT Gruppe [Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale, effects, toxicology and clinical experiences. ENDIT Group]. Ugeskr Laeger. 1994 Jan 24; 156 (4): 461–5. Danish. https://pubmed.ncbi.nlm.nih.gov/8140661/

32. Yamamoto H, Okamoto H. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Biochem Biophys Res Commun. 1980 Jul 16; 95 (1): 474–81. DOI: 10.1016/0006-291x(80)90762-7

33. Uchigata Y, Yamamoto H, Nagai H, Okamoto H. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes. 1983 Apr; 32 (4): 316–8. DOI: 10.2337/diab.32.4.316

34. Szabo C. PARP as a Drug Target for the Therapy of Diabetic Cardiovascular Dysfunction. Drug News Perspect. 2002 May; 15 (4): 197–205. DOI: 10.1358/dnp.2002.15.4.840052

35. Xiang D, Zhang Q, Wang YT. Effectiveness of niacin supplementation for patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020 Jul 17; 99 (29): e21235. DOI: 10.1097/MD.0000000000021235

36. Davis RE, Calder JS, Curnow DH. Serum pyridoxal and folate concentrations in diabetics. Pathology. 1976 Apr; 8 (2): 151–6. DOI: 10.3109/00313027609094441

37. Wilson RG, Davis RE. Serum pyridoxal concentrations in children with diabetes mellitus. Pathology. 1977 Apr; 9 (2): 95–8. DOI: 10.3109/00313027709085244

38. Kelly PJ, Shih VE, Kistler JP, Barron M, Lee H, Mandell R, Furie KL. Low vitamin B6 but not homocyst(e) ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke. 2003 Jun; 34 (6): e51–4. DOI: 10.1161/01.STR.0000071109.23410.AB

39. Wilmink AB, Welch AA, Quick CR, Burns PJ, Hubbard CS, Bradbury AW, Day NE. Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg. 2004 Mar; 39 (3): 513–6. DOI: 10.1016/j.jvs.2003.09.046

40. van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia. 2002 Jul; 45 (7): 1004–10. DOI: 10.1007/s00125‑002‑0862‑1

41. MacKenzie KE, Wiltshire EJ, Gent R, Hirte C, Piotto L, Couper JJ. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics. 2006 Jul; 118 (1): 242–53. DOI: 10.1542/peds.2005-2143

42. Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998 Jan 27; 97 (3): 237–41. DOI: 10.1161/01.cir.97.3.237

43. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R, Rabelink TJ. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res. 2000 Jun 9; 86 (11): 1129–34. DOI: 10.1161/01.res.86.11.1129

44. Zhao JV, Schooling CM, Zhao JX. The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Ann Epidemiol. 2018 Apr; 28 (4): 249–257.e1. DOI: 10.1016/j.annepidem.2018.02.001

45. Asbaghi O, Ashtary-Larky D, Bagheri R, Moosavian SP, Olyaei HP, Nazarian B, Rezaei Kelishadi M, Wong A, Candow DG, Dutheil F, Suzuki K, Alavi Naeini A. Folic Acid Supplementation Improves Glycemic Control for Diabetes Prevention and Management: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021 Jul 9; 13 (7): 2355. DOI: 10.3390/nu13072355

46. Sudchada P, Saokaew S, Sridetch S, Incampa S, Jaiyen S, Khaithong W. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012 Oct; 98 (1): 151–8. DOI: 10.1016/j.diabres.2012.05.027

47. Jiang Z, Qu H, Chen K, Gao Z. Beneficial effects of folic acid on inflammatory markers in the patients with metabolic syndrome: Meta-analysis and meta-regression of data from 511 participants in 10 randomized controlled trials. Crit Rev Food Sci Nutr. 2024; 64 (16): 5450–5461. DOI: 10.1080/10408398.2022.2154743

48. Asbaghi O, Ashtary-Larky D, Bagheri R, Nazarian B, Pourmirzaei Olyaei H, Rezaei Kelishadi M, Nordvall M, Wong A, Dutheil F, Naeini AA. Beneficial effects of folic acid supplementation on lipid markers in adults: A GRADE-assessed systematic review and dose-response meta-analysis of data from 21,787 participants in 34 randomized controlled trials. Crit Rev Food Sci Nutr. 2022; 62 (30): 8435–8453. DOI: 10.1080/10408398.2021.1928598

49. Asbaghi O, Ghanavati M, Ashtary-Larky D, Bagheri R, Rezaei Kelishadi M, Nazarian B, Nordvall M, Wong A, Dutheil F, Suzuki K, Alavi Naeini A. Effects of Folic Acid Supplementation on Oxidative Stress Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Antioxidants (Basel). 2021 May 28; 10 (6): 871. DOI: 10.3390/antiox10060871

50. Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract. 2011 Oct; 94 (1): 33–8. DOI: 10.1016/j.diabres.2011.07.003

51. Kakarlapudi Y, Kondabolu SK, Tehseen Z, Khemani V, J SK, Nousherwani MD, Saleem F, Abdelhameed AN. Effect of Metformin on Vitamin B12 Deficiency in Patients With Type 2 Diabetes Mellitus and Factors Associated With It: A Meta-Analysis. Cureus. 2022 Dec 7; 14 (12): e32277. DOI: 10.7759/cureus.32277

52. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, Bray GA, Schade DS, Temprosa MG, White NH, Crandall JP; Diabetes Prevention Program Research Group. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016 Apr; 101 (4): 1754–61. DOI: 10.1210/jc.2015-3754

53. Yang X, Hu R, Zhu Y, Wang Z, Hou Y, Su K, He X, Song G. Meta-analysis of Serum Vitamin B12 Levels and Diabetic Retinopathy in Type 2 Diabetes. Arch Med Res. 2023 Jan; 54 (1): 64–73. DOI: 10.1016/j.arcmed.2022.12.006

54. Karedath J, Batool S, Arshad A, Khalique S, Raja S, Lal B, Anirudh Chunchu V, Hirani S. The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials. Cureus. 2022 Nov 22; 14 (11): e31783. DOI: 10.7759/cureus.31783

55. Elbarbary NS, Ismail EAR, Zaki MA, Darwish YW, Ibrahim MZ, El-Hamamsy M. Vitamin B complex supplementation as a homocysteine-lowering therapy for early stage diabetic nephropathy in pediatric patients with type 1 diabetes: A randomized controlled trial. Clin Nutr. 2020 Jan;39(1):49–56. DOI: 10.1016/j.clnu.2019.01.006.

56. Farah S, Yammine K. A systematic review on the efficacy of vitamin B supplementation on diabetic peripheral neuropathy. Nutr Rev. 2022 Apr 8; 80 (5): 1340–1355. DOI: 10.1093/nutrit/nuab116

57. Spence JD, Yi Q, Hankey GJ. B vitamins in stroke prevention: time to reconsider. Lancet Neurol. 2017 Sep; 16 (9): 750–760. DOI: 10.1016/S1474-4422 (17) 30180‑1

58. Akimbekov NS, Coban SO, Atfi A, Razzaque MS. The role of magnesium in pancreatic beta-cell function and homeostasis. Front Nutr. 2024 Sep 25; 11: 1458700. DOI: 10.3389/fnut.2024.1458700

59. Catalano A, Bellone F, Chilà D, Loddo S, Corica F. Magnesium disorders: Myth or facts? Eur J Intern Med. 2019 Dec; 70: e22–e24. DOI: 10.1016/j.ejim.2019.10.013

60. Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV, Pinotti L, Maier JA, Cazzola R. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients. 2021 Jan 22; 13 (2): 320. DOI: 10.3390/nu13020320

61. Han M, Zhang Y, Fang J, Sun M, Liu Q, Ma Z, Hu D, Gong X, Liu Y, Jin L, Liu Z, Ma Y. Associations between dietary magnesium intake and hypertension, diabetes, and hyperlipidemia. Hypertens Res. 2024 Feb; 47 (2): 331–341. DOI: 10.1038/s41440-023-01439-z

62. Han H, Fang X, Wei X, Liu Y, Jin Z, Chen Q, Fan Z, Aaseth J, Hiyoshi A, He J, Cao Y. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J. 2017 May 5; 16 (1): 26. DOI: 10.1186/s12937‑017‑0247‑4

63. Moore-Schiltz L, ANutritionlbert JM, Singer ME, Swain J, Nock NL. Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Examination (NHANES) 2001–2010 data. Br J Nutr. 2015 Sep 28; 114 (6): 924–35.

64. Zhao B, Deng H, Li B, Chen L, Zou F, Hu L, Wei Y, Zhang W. Association of magnesium consumption with type 2 diabetes and glucose metabolism: A systematic review and pooled study with trial sequential analysis. Diabetes Metab Res Rev. 2020 Mar; 36 (3): e3243.

65. Mather HM, Nisbet JA, Burton GH, Poston GJ, Bland JM, Bailey PA, Pilkington TR. Hypomagnesaemia in diabetes. Clin Chim Acta. 1979 Jul 16; 95 (2): 235–42. DOI: 10.1016/0009-8981(79)90364‑4

66. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995 Jul; 48 (7): 927–40. DOI: 10.1016/0895–4356(94)00200-a

67. Wälti MK, Zimmermann MB, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly. 2003 May 17; 133 (19–20): 289–92. DOI: 10.4414/smw.2003.10170

68. Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, Yanagawa N, Pham PT. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol. 2005 Jun; 63 (6): 429–36. DOI: 10.5414/cnp63429

69. Zahra H, Berriche O, Mizouri R, Boukhayatia F, Khiari M, Gamoudi A, Lahmar I, Ben Amor N, Mahjoub F, Zayet S, Jamoussi H. Plasmatic Magnesium Deficiency in 101 Outpatients Living with Type 2 Diabetes Mellitus. Clin Pract. 2021 Oct 27; 11 (4): 791–800. DOI: 10.3390/clinpract11040095

70. Ismail AAA, Ismail Y, Ismail AA. Chronic magnesium deficiency and human disease; time for reappraisal? QJM. 2018 Nov 1; 111 (11): 759–763. DOI: 10.1093/qjmed/hcx186

71. Bouras H, Roig SR, Kurstjens S, Tack CJJ, Kebieche M, de Baaij JHF, Hoenderop JGJ. Metformin regulates TRPM6, a potential explanation for magnesium imbalance in type 2 diabetes patients. Can J Physiol Pharmacol. 2020 Jun; 98 (6): 400–411. DOI: 10.1139/cjpp‑2019-0570

72. Askari M, Mozaffari H, Jafari A, Ghanbari M, Darooghegi Mofrad M. The effects of magnesium supplementation on obesity measures in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021; 61 (17): 2921–2937. DOI: 10.1080/10408398.2020.1790498

73. Rafiee M, Ghavami A, Rashidian A, Hadi A, Askari G. The effect of magnesium supplementation on anthropometric indices: a systematic review and dose-response meta-analysis of clinical trials. Br J Nutr. 2021 Mar 28; 125 (6): 644–656. DOI: 10.1017/S0007114520003037

74. Sakaguchi Y, Shoji T, Hayashi T, Suzuki A, Shimizu M, Mitsumoto K, Kawabata H, Niihata K, Okada N, Isaka Y, Rakugi H, Tsubakihara Y. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease. Diabetes Care. 2012 Jul; 35 (7): 1591–7. DOI: 10.2337/dc12-0226

75. Kumar SR, Kumar KGS, Gayathri R. Hypomagnesemia in Patients with Type 2 Diabetes Mellitus. J Assoc Physicians India. 2024 Jul;72(7):25–28. DOI: 10.59556/japi.72.0410.

76. Kazmi SKS, Farooq M, Iftikhar I, Fatima N, Shahzad M, Ijaz AU, Khalid H. Association of Hypomagnesemia With Diabetic Complications. Cureus. 2024 Mar 20; 16 (3): e56605. DOI: 10.7759/cureus.56605

77. Chu C, Zhao W, Zhang Y, Li L, Lu J, Jiang L, Wang C, Jia W. Low serum magnesium levels are associated with impaired peripheral nerve function in type 2 diabetic patients. Sci Rep. 2016 Sep 7; 6: 32623. DOI: 10.1038/srep32623

78. Mamilla M, Yartha SGR, Tuli R, Konipineni S, Rayaprolu DT, Borgharkar G, Kalluru PKR, Thugu TR. Role of Magnesium in Diabetic Nephropathy for Better Outcomes. Cureus. 2023 Aug 7; 15 (8): e43076. DOI: 10.7759/cureus.43076

79. Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Zambrano-Galvan G, Guerrero-Romero F. Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Pharm Des. 2017; 23 (31): 4678–4686. DOI: 10.2174/1381612823666170525153605

80. Alharran AM, Alzayed MM, Jamilian P, Prabahar K, Kamal AH, Alotaibi MN, Elshaer OE, Alhatm M, Masmoum MD, Hernández-Wolters B, Sindi R, Kord-Varkaneh H, Abu-Zaid A. Impact of Magnesium Supplementation on Blood Pressure: An Umbrella Meta-Analysis of Randomized Controlled Trials. Curr Ther Res Clin Exp. 2024 Jul 31; 101: 100755. DOI: 10.1016/j.curtheres.2024.100755

81. Marques BCAA, Klein MRST, da Cunha MR, de Souza Mattos S, de Paula Nogueira L, de Paula T, Corrêa FM, Oigman W, Neves MF. Effects of Oral Magnesium Supplementation on Vascular Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials. High Blood Press Cardiovasc Prev. 2020 Feb; 27 (1): 19–28. DOI: 10.1007/s40292-019-00355-z

82. Darooghegi Mofrad M, Djafarian K, Mozaffari H, Shab-Bidar S. Effect of magnesium supplementation on endothelial function: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis. 2018 Jun; 273: 98–105. DOI: 10.1016/j.atherosclerosis.2018.04.020

83. Maret W. Chromium Supplementation in Human Health, Metabolic Syndrome, and Diabetes. Met Ions Life Sci. 2019 Jan 14; 19: /books/9783110527872/9783110527872-015/9783110527872-015.xml. DOI: 10.1515/9783110527872-015

84. Afzal S, Ocasio Quinones GA. Chromium Deficiency. 2024 Jun 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. PMID: 35881755.

85. Chen J, Kan M, Ratnasekera P, Deol LK, Thakkar V, Davison KM. Blood Chromium Levels and Their Association with Cardiovascular Diseases, Diabetes, and Depression: National Health and Nutrition Examination Survey (NHANES) 2015–2016. Nutrients. 2022 Jun 28; 14 (13): 2687. DOI: 10.3390/nu14132687

86. Roussel AM, Andriollo-Sanchez M, Ferry M, Bryden NA, Anderson RA. Food chromium content, dietary chromium intake and related biological variables in French free-living elderly. Br J Nutr. 2007 Aug; 98 (2): 326–31. DOI: 10.1017/S000711450770168X

87. Berger MM, Shenkin A, Schweinlin A, Amrein K, Augsburger M, Biesalski HK, Bischoff SC, Casaer MP, Gundogan K, Lepp HL, de Man AME, Muscogiuri G, Pietka M, Pironi L, Rezzi S, Cuerda C. ESPEN micronutrient guideline. Clin Nutr. 2022 Jun; 41 (6): 1357–1424. DOI: 10.1016/j.clnu.2022.02.015

88. Xia J, Yu J, Xu H, Zhou Y, Li H, Yin S, Xu D, Wang Y, Xia H, Liao W, Wang S, Sun G. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol Res. 2023 Feb; 188: 106647. DOI: 10.1016/j.phrs.2023.106647

89. Zhao F, Pan D, Wang N, Xia H, Zhang H, Wang S, Sun G. Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis. Biol Trace Elem Res. 2022 Feb; 200 (2): 516–525. DOI: 10.1007/s12011‑021‑02693‑3

90. Asbaghi O, Fatemeh N, Mahnaz RK, Ehsan G, Elham E, Behzad N, Damoon AL, Amirmansour AN. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020 Nov; 161: 105098. DOI: 10.1016/j.phrs.2020.105098

91. Lari A, Fatahi S, Sohouli MH, Shidfar F. The Impact of Chromium Supplementation on Blood Pressure: A Systematic Review and Dose-Response Meta-Analysis of Randomized-Controlled Trials. High Blood Press Cardiovasc Prev. 2021 Jul; 28 (4): 333–342. DOI: 10.1007/s40292‑021‑00456‑8

92. Zhang X, Cui L, Chen B, Xiong Q, Zhan Y, Ye J, Yin Q. Effect of chromium supplementation on hs-CRP, TNF-α and IL‑6 as risk factor for cardiovascular diseases: A meta-analysis of randomized-controlled trials. Complement Ther Clin Pract. 2021 Feb; 42: 101291. DOI: 10.1016/j.ctcp.2020.101291

93. Amini MR, Sheikhhossein F, Djafari F, Jafari A, Djafarian K, Shab-Bidar S. Effects of chromium supplementation on oxidative stress biomarkers. Int J Vitam Nutr Res. 2023 Jun; 93 (3): 241–251. DOI: 10.1024/0300–9831/a000706

94. Zhao Y, Zhou M, Shang Y, Dou M, Gao S, Yang H, Zhang F. Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance. Diab Vasc Dis Res. 2024 Jan-Feb; 21 (1): 14791641241228156

95. Taylor CG. Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. Biometals. 2005 Aug; 18 (4): 305–12. DOI: 10.1007/s10534-005-3686-x

96. Ahmad R, Shaju R, Atfi A, Razzaque MS. Zinc and Diabetes: A Connection between Micronutrient and Metabolism. Cells. 2024 Aug 15; 13 (16): 1359. DOI: 10.3390/cells13161359

97. Wang X, Wu W, Zheng W, Fang X, Chen L, Rink L, Min J, Wang F. Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019 Jul 1; 110 (1): 76–90. DOI: 10.1093/ajcn/nqz041

98. Soinio M, Marniemi J, Laakso M, Pyörälä K, Lehto S, Rönnemaa T. Serum zinc level and coronary heart disease events in patients with type 2 diabetes. Diabetes Care. 2007 Mar; 30 (3): 523–8. DOI: 10.2337/dc06-1682

99. Arreola F, Paniagua R, Díaz-Bensussen S, Urquieta B, López-Montaño E, Partida-Hernández G, Villalpando S. Bone mineral content, 25-hydroxycalciferol and zinc serum levels in insulin-dependent (type I) diabetic patients. Arch Invest Med (Mex). 1990 Apr-Jun; 21 (2): 195–9. https://pubmed.ncbi.nlm.nih.gov/2103709/

100. Maser RE, Stabley JN, Lenhard MJ, Owusu-Griffin P, Provost-Craig MA, Farquhar WB. Zinc intake and biochemical markers of bone turnover in type 1 diabetes. Diabetes Care. 2008 Dec; 31 (12): 2279–80. DOI: 10.2337/dc08–1068. Epub 2008 Sep 22

101. Nazari M, Nikbaf-Shandiz M, Pashayee-Khamene F, Bagheri R, Goudarzi K, Hosseinnia NV, Dolatshahi S, Omran HS, Amirani N, Ashtary-Larky D, Asbaghi O, Ghanavati M. Zinc Supplementation in Individuals with Prediabetes and type 2 Diabetes: a GRADE-Assessed Systematic Review and Dose-Response Meta-analysis. Biol Trace Elem Res. 2024 Jul; 202 (7): 2966–2990. DOI: 10.1007/s12011‑023‑03895‑7

102. Ghaedi K, Ghasempour D, Jowshan M, Zheng M, Ghobadi S, Jafari A. Effect of zinc supplementation in the management of type 2 diabetes: A grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2024; 64 (25): 9228–9239. DOI: 10.1080/10408398.2023.2209802

103. Cai L, Tan Y, Watson S, Wintergerst K. Diabetic cardiomyopathy – Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways. Toxicol Appl Pharmacol. 2023 Oct 15; 477: 116694. DOI: 10.1016/j.taap.2023.116694

104. Pompano LM, Boy E. Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Adv Nutr. 2021 Feb 1; 12 (1): 141–160. DOI: 10.1093/advances/nmaa087. Erratum in: Adv Nutr. 2021 Jun 1; 12 (3): 1049. DOI: 10.1093/advances/nmab052

105. Jayawardena R, Ranasinghe P, Kodithuwakku W, Dalpatadu C, Attia J. Zinc supplementation in prediabetes mellitus. Minerva Endocrinol (Torino). 2022 Sep; 47 (3): 334–343. DOI: 10.23736/S2724-6507.21.03234-X

106. Baj J, Flieger W, Barbachowska A, Kowalska B, Flieger M, Forma A, Teresiński G, Portincasa P, Buszewicz G, Radzikowska-Büchner E, Flieger J. Consequences of Disturbing Manganese Homeostasis. Int J Mol Sci. 2023 Oct 6; 24 (19): 14959. DOI: 10.3390/ijms241914959

107. el-Yazigi A, Hannan N, Raines DA. Urinary excretion of chromium, copper, and manganese in diabetes mellitus and associated disorders. Diabetes Res. 1991 Nov; 18 (3): 129–34. https://pubmed.ncbi.nlm.nih.gov/1841823/

108. Chen H., Cui Z., Lu W., Wang P., Wang J., Zhou Z., Zhang N., Wang Z., Lin T., Song Y., et al. Association between serum manganese levels and diabetes in Chinese adults with hypertension. J. Clin. Hypertens. 2022; 24: 918–927. DOI: 10.1111/jch.14520

109. Gong JH, Lo K, Liu Q, Li J, Lai S, Shadyab AH, Arcan C, Snetselaar L, Liu S. Dietary Manganese, Plasma Markers of Inflammation, and the Development of Type 2 Diabetes in Postmenopausal Women: Findings From the Women’s Health Initiative. Diabetes Care. 2020 Jun; 43 (6): 1344–1351. DOI: 10.2337/dc20-0243

110. Burlet E, Jain SK. Manganese supplementation reduces high glucose-induced monocyte adhesion to endothelial cells and endothelial dysfunction in Zucker diabetic fatty rats. J Biol Chem. 2013 Mar 1; 288 (9): 6409–16. DOI: 10.1074/jbc.M112.447805

111. Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. 2011 Jan 26; 4: 53–60. DOI: 10.2147/DMSO.S16691

112. Kancherla V, Garn JV, Zakai NA, Williamson RS, Cashion WT, Odewole O, Judd SE, Oakley GP Jr. Multivitamin Use and Serum Vitamin B12 Concentrations in Older-Adult Metformin Users in REGARDS, 2003–2007. PLoS One. 2016 Aug 11; 11 (8): e0160802. DOI: 10.1371/journal.pone.0160802

113. Barringer TA, Kirk JK, Santaniello AC, Foley KL, Michielutte R. Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 Mar 4; 138 (5): 365–71. DOI: 10.7326/0003‑4819‑138‑5‑200303040‑00005

114. Shikh EV, Makhova AA, Chemeris AV, Tormyshov IA. [Iatrogenic deficits of micronutrients]. Vopr Pitan. 2021; 90 (4): 53–63. Russian. DOI: 10.33029/0042‑8833‑2021‑90‑4‑53‑63

115. Sole MJ, Jeejeebhoy KN. Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz. 2002 Mar;27(2):174–8. DOI: 10.1007/s00059‑002‑2360‑0.

116. Suter PM, Vetter W. Diuretics and vitamin B1: are diuretics a risk factor for thiamin malnutrition? Nutr Rev. 2000 Oct; 58 (10): 319–23. DOI: 10.1111/j.1753-4887.2000.tb01827.x

117. Zhou Z, Sun B, Yu D, Zhu C. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus. Front Cell Infect Microbiol. 2022 Feb 15; 12: 834485. DOI: 10.3389/fcimb.2022.834485

118. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019 Feb 2; 393 (10170): 434–445. DOI: 10.1016/S0140–6736(18)31809‑9. Epub 2019 Jan 10. Erratum in: Lancet. 2019 Feb 2; 393 (10170): 406. DOI: 10.1016/S0140–6736(19)30119‑9

119. Reynolds AN, Akerman AP, Mann J. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLoS Med. 2020 Mar 6; 17 (3): e1003053. DOI: 10.1371/journal.pmed.1003053

120. Davison KM, Temple NJ. Cereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox. J Diabetes Complications. 2018 Feb; 32 (2): 240–245. DOI: 10.1016/j.jdiacomp.2017.11.002

121. Tawfick MM, Xie H, Zhao C, Shao P, Farag MA. Inulin fructans in diet: Role in gut homeostasis, immunity, health outcomes and potential therapeutics. Int J Biol Macromol. 2022 May 31; 208: 948–961. DOI: 10.1016/j.ijbiomac.2022.03.218

122. Le Bastard Q, Chapelet G, Javaudin F, Lepelletier D, Batard E, Montassier E. The effects of inulin on gut microbial composition: a systematic review of evidence from human studies. Eur J Clin Microbiol Infect Dis. 2020 Mar; 39 (3): 403–413. DOI: 10.1007/s10096-019-03721-w

123. Wang X, Wang T, Zhang Q, Xu L, Xiao X. Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes. Int J Endocrinol. 2021 Jun 29; 2021: 5579369. DOI: 10.1155/2021/5579369

124. Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Måge I, Rud I, Aas AM. Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial. Eur J Nutr. 2020 Oct; 59 (7): 3325–3338. DOI: 10.1007/s00394‑020‑02282‑5. Epub 2020 May 21. Erratum in: Eur J Nutr. 2020 Oct; 59 (7): 3339–3340. DOI: 10.1007/s00394‑020‑02314‑0

125. Zhang W, Tang Y, Huang J, Yang Y, Yang Q, Hu H. Efficacy of inulin supplementation in improving insulin control, HbA1c and HOMA-IR in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. J Clin Biochem Nutr. 2020 May; 66 (3): 176–183. DOI: 10.3164/jcbn.19-103

126. Reimer RA, Theis S, Zanzer YC. The effects of chicory inulin-type fructans supplementation on weight management outcomes: systematic review, meta-analysis, and meta-regression of randomized controlled trials. Am J Clin Nutr. 2024 Nov; 120 (5): 1245–1258. DOI: 10.1016/j.ajcnut.2024.09.019. Epub 2024 Sep 21. Erratum in: Am J Clin Nutr. 2025 Jul;122 (1): 368–370. DOI: 10.1016/j.ajcnut.2025.05.013

127. Li L, Li P, Xu L. Assessing the effects of inulin-type fructan intake on body weight, blood glucose, and lipid profile: A systematic review and meta-analysis of randomized controlled trials. Food Sci Nutr. 2021 Jun 21; 9 (8): 4598–4616. DOI: 10.1002/fsn3.2403

128. Coxam V. Current data with inulin-type fructans and calcium, targeting bone health in adults. J Nutr. 2007 Nov; 137 (11 Suppl): 2527S‑2533S. DOI: 10.1093/jn/137.11.2527s

129. Schuchardt JP, Hahn A. Intestinal Absorption and Factors Influencing Bioavailability of Magnesium-An Update. Curr Nutr Food Sci. 2017 Nov; 13 (4): 260–278. DOI: 10.2174/1573401313666170427162740

130. Hughes RL, Alvarado DA, Swanson KS, Holscher HD. The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review. Adv Nutr. 2022 Mar; 13 (2): 492–529. DOI: 10.1093/advances/nmab119

131. Iqbal S, Ahmed W, Zafar S, Farooq U, Abid J, Shah HBU, Akram S, Ghazanfar M, Ahmad AMR. Effect of inulin, galacto oligosaccharides and iron fortification on iron deficiency anemia among women of reproductive age; a randomized controlled trial. Front Nutr. 2022 Nov 14; 9: 1028956. DOI: 10.3389/fnut.2022.1028956

132. Bailey CJ. Metformin: historical overview. Diabetologia. 2017 Sep; 60 (9): 1566–1576. DOI: 10.1007/s00125-017-4318-z

133. Kumar S, Mittal A, Babu D, Mittal A. Herbal Medicines for Diabetes Management and its Secondary Complications. Curr Diabetes Rev. 2021; 17 (4): 437–456. DOI: 10.2174/1573399816666201103143225

134. McKennon SA. Non-Pharmaceutical Intervention Options For Type 2 Diabetes: Complementary & Integrative Health Approaches (Including Natural Products And Mind/Body Practices). 2024 Jul 6. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. PMID: 25905290.

135. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Gymnema. 2024 Oct 28. PMID: 39666848.

136. Kameswaran S., Perumal K. (2020). Extraction and Purification of Gymnemic Acid from Gymnema sylvestre R. Br. In: Khasim S. M., Long C., Thammasiri K., Lutken H. (eds) Medicinal Plants: Biodiversity, Sustainable Utilization and Conservation. Springer, Singapore. https://doi.org/10.1007/978‑981‑15‑1636‑8_29

137. Kant S. Gymnema sylvestre, Anti-Diabetic Effects and Mechanisms. IJREAS. 2020 Jun; 10 (6): 1–3. https://euroasiapub.org/wp-content/uploads/IJREASJune2020.pdf

138. Di Fabio G, Romanucci V, Di Marino C, Pisanti A, Zarrelli A. Gymnema sylvestre R. Br., an Indian medicinal herb: traditional uses, chemical composition, and biological activity. Curr Pharm Biotechnol. 2015; 16 (6): 506–16. DOI: 10.2174/138920101606150407112903

139. Devangan S, Varghese B, Johny E, Gurram S, Adela R. The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Phytother Res. 2021 Dec; 35 (12): 6802–6812. DOI: 10.1002/ptr.7265

140. Zamani M, Ashtary-Larky D, Nosratabadi S, Bagheri R, Wong A, Rafiei MM, Asiabar MM, Khalili P, Asbaghi O, Davoodi SH. The effects of Gymnema Sylvestre supplementation on lipid profile, glycemic control, blood pressure, and anthropometric indices in adults: A systematic review and meta-analysis. Phytother Res. 2023 Mar; 37 (3): 949–964. DOI: 10.1002/ptr.7585

141. Buccato DG, Ullah H, De Lellis LF, Morone MV, Larsen DS, Di Minno A, Cordara M, Piccinocchi R, Baldi A, Greco A, Santonastaso S, Sacchi R, Daglia M. Efficacy and Tolerability of a Food Supplement Based on Zea mays L., Gymnema sylvestre (Retz.) R.br.ex Sm, Zinc and Chromium for the Maintenance of Normal Carbohydrate Metabolism: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2024 Jul 29; 16 (15): 2459. DOI: 10.3390/nu16152459

142. Nani A, Bertuzzi F, Meneghini E, Mion E, Pintaudi B. Combined Inositols, α-Lactalbumin, Gymnema Sylvestre and Zinc Improve the Lipid Metabolic Profile of Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial. J Clin Med. 2023 Dec 13; 12 (24): 7650. DOI: 10.3390/jcm12247650

143. Preuss HG, Bagchi D, Bagchi M, Rao CV, Dey DK, Satyanarayana S. Effects of a natural extract of (–)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab. 2004 May; 6 (3): 171–80. DOI: 10.1111/j.1462-8902.2004.00328.x

144. Turner S, Diako C, Kruger R, Wong M, Wood W, Rutherfurd-Markwick K, Stice E, Ali A. The Effect of a 14-Day gymnema sylvestre Intervention to Reduce Sugar Cravings in Adults. Nutrients. 2022 Dec 12; 14 (24): 5287. DOI: 10.3390/nu14245287

145. Tiwari P, Mishra BN, Sangwan NS. Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant. Biomed Res Int. 2014; 2014: 830285. DOI: 10.1155/2014/830285